Objective: To determine and compare the accuracy of Nexframe and the Leksell stereotactic frame in deep brain stimulation (DBS) procedures. Background: The ‘frameless' Nexframe uses bone fiducials rather than a head-mounted frame, which offers potential benefits for both the patient and the surgical team. Accuracy of lead implantation and factors affecting this accuracy are of crucial importance but have not been extensively studied for the frameless system. Design/Methods: The location of 194 (Leksell frame, n = 116; Nexframe, n = 78) DBS leads was determined on postoperative MRI. Obtained stereotactic coordinates were compared with expected intraoperative target coordinates. Resulting absolute errors in the X (medial-lateral), Y (anterior-posterior), and Z (dorsal-ventral) coordinates (ΔX, ΔY, and ΔZ) were then used to calculate the vector error (VE). The vector error describes the total error in 3-D space and represents our main outcome measure. Results: The vector error (mean ± SD) was 2.8 ± 1.3 for Nexframe and 2.5 ± 1.2 for the Leksell frame (p = 0.43). For Nexframe, absolute X, Y, and Z errors were 1.4 ± 1.3, 1.7 ± 1.2, and 1.0 ± 0.9 mm. For the Leksell frame, the absolute X, Y, and Z errors were 1.4 ± 1.0, 1.2 ± 1.0, and 1.3 ± 0.9 mm. On the anterior-posterior plane (Y coordinate), the Leksell frame was more accurate than Nexframe (p = 0.04). In contrast, Nexframe was more accurate on the dorsal-ventral plane (Z coordinate) (p = 0.04). There was no difference in accuracy between the two methods on the medial-lateral plane (X coordinate). Conclusion: This comparison of Nexframe and the Leksell frame shows that both techniques have equivalent overall 3-D accuracy.

1.
Walker AE: The development of the concept of cerebral localization in the nineteenth century. Bull Hist Med 1957;31:99-121.
2.
Meyers R: The modification of alternating tremors, rigidity and festination by surgery of basal ganglia. Assoc Nerv Ment Dis 1942;20:602-665.
3.
Clarke RH, Horsley V: On a method of investigating the deep ganglia and tracts of the central nervous system (cerebellum). Br Med J 1906;2:1799-1800.
4.
Spiegel EA, Wycis HT, Marks M, Lee AS: Stereotaxic apparatus for operations on the human brain. Science 1947;106:349-350.
5.
Ondo WG, Bronte-Stewart H; DBS Study Group: The North American survey of placement and adjustment strategies for deep brain stimulation. Stereotact Funct Neurosurg 2005;83:142-147.
6.
Starr PA, Chirstine CW, Theodospoulos PV, Lindsey N, Byrd D, Mosely A, Marks WJ Jr: Implantation of deep brain simulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002;97;370-387.
7.
Maciunas RJ, Galloway RL Jr, Latimer JW: The application accuracy of stereotactic frames. Neurosurgery 1994;35:682-694.
8.
Woerdeman PA, Willems PW, Noordmans HJ, Tulleken CA, van der Sprenkel JW: Application of accuracy in frameless image-guided neurosurgery: a comparison study of three patient-to-image registration methods. J Neurosurg 2007;106:1012-1016.
9.
Kelman C, Ramakrishnan V, Davies A, Holloway K: Analysis of stereotactic accuracy of the Cosman-Robert-Wells frame and Nexframe frameless systems in deep brain stimulation surgery. Sterotactic Funct Neurosurg 2010;88:288-295.
10.
Holloway KL, Gaede SE, Starr PA, Rosenow JM, Ramakrishnan V, Henderson JM: Frameless stereotaxy using bone fiducial markers for deep brain stimulation. J Neurosurg 2005;103:404-413.
11.
Tai CH, Wu RM, Lin CH, Pan MK, Chen YF, Liu HM, Lu HH, Tsai CW, Tseng SH: Deep brain stimulation therapy for Parkinson's disease using frameless stereotaxy: comparison with frame-based surgery. Eur J Neurol 2010;17:1377-1385.
12.
Brontë-Stewart H, Louie S, Batya S, Henderson JM: Clinical motor outcome of bilateral subthalamic nucleus deep-brain stimulation for Parkinson's disease using image-guided frameless stereotaxy. Neurosurg 2010;67:1088-1093.
13.
Bjartmarz H, Rehncrona S: Comparison of accuracy and precision between frame-based and frameless stereotactic navigation for deep brain stimulation electrode implantation. Stereotact Funct Neurosurg 2007;85:235-242.
14.
Fukaya C, Sumi K, Otaka T, Obuchi T, Kano T, Kobayashi K, Oshima H, Yamamoto T, Katayama Y: Nexframe frameless stereotaxy with multitract microrecording: accuracy evaluated by frame-based stereotactic X-ray. Stereotact Funct Neurosurg 2010;88:163-168.
15.
Pollo C, Villemure JG, Vingerhoets F, Ghika J, Maeder P, Meuli R: Magnetic resonance artifact induced by the electrode Activa 3389: an in vitro and in vivo study. Acta Neurochir 2004;146:161-164.
16.
Verhagen Metman L, Pilitsis JG, Stebbins GT, Bot M, Bakay RA: Intraoperative X-ray to measure distance between DBS leads: a reliability study. Mov Disord 2012;27:1056-1059.
17.
Pinto S, Le Bas JF, Castana L, Krack P, Pollak P, Benabid AL: Comparison of two techniques to postoperatively localize the electrode contacts used for subthalamic nucleus stimulation. Neurosurg 2007;60:285-292.
18.
Lee JY, Kim JW, Lee JY, Lim YH, Kim C, Kim DG, Jeon BS, Paek SH: Is MRI a reliable tool to locate the electrode after deep brain stimulation surgery? Comparison study of CT and MRI for the localization of electrodes after DBS. Acta Neurochir (Wien) 2010;152:2029-2036.
19.
Thani NB, Bala A, Swann GB, Lind CR: Accuracy of postoperative computed tomography and magnetic resonance image fusion for assessing deep brain stimulation electrodes. Neurosurgery 2011;69:207-214.
20.
Sumanaweera TS, Adler JR Jr, Napel S, Glover GH: Characterization of spatial distortion in magnetic resonance imaging and its implications for stereotactic surgery. Neurosurgery 1994;35:696-703, discussion 703-704.
21.
Pinsker MO, Herzog J, Falk D, Volkmann J, Deuschl G, Mehdorn M: Accuracy and distortion of deep brain stimulation electrodes on postoperative MRI and CT. Zentralbl Neurochir 2008;69:144-147.
22.
Skare S, Andersson JL: Correction of MR image distortions induced by metallic objects using a 3D cubic B-spline basis set: application to stereotactic surgical planning. Magn Reson Med 2005;54:169-181.
23.
Fiegele T, Feuchtner G, Sohm F, Bauer R, Anton JV, Gotwald T, Twerdy K, Eisner W: Accuracy of stereotactic electrode placement in deep brain stimulation by intraoperative computed tomography. Parkinsonism Relat Disord 2008;14:595-599.
24.
Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS: Subthalamic nucleus deep brain stimulation placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 2010;112:479-490.
25.
Smith AP, Bakay RA: Frameless deep brain stimulation using intraoperative O-arm technology. J Neurosurg 2011;115:301-309.
26.
Elias WJ, Fu KM, Frysinger RC: Cortical and subcortical brain shift during stereotactic procedures. J Neurosurg 2007;107:983-988.
27.
van den Munckhof P, Contarino MF, Bour LJ, Speelman JD, de Bie RM, Schuurman PR: Postoperative curving and upward displacement of deep brain stimulation electrodes caused by brain shift. Neurosurgery 2010;67:49-53.
28.
Miyagi Y, Shima F, Sasaki T: Brain shift: an error factor during implantation of deep brain stimulation electrodes. J Neurosurg 2007;107:989-997.
29.
Halpern CH, Danish SF, Baltuch GH, Jaggi JL: Brain shift during deep brain stimulation surgery for Parkinson's disease. Stereotact Funct Neurosurg 2008;86:37-43.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.